FDA grants IND clearance for Indapta’s multiple sclerosis treatment trial
The trial will be led by Stanford University and the University of California, San Francisco, US.
07 August 2024
07 August 2024
The trial will be led by Stanford University and the University of California, San Francisco, US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.